DeepIntent Outcomes Hits 65% of Campaign Impressions, Meeting Healthcare Advertisers’ Demand for Improved Measurement and Optimization

Matterkind uses DeepIntent Outcomes’ patented technology to improve audience quality and script performance

DeepIntent, the leading healthcare advertising technology company built to influence better patient health and business outcomes, announced the significant adoption of its patented, award-winning advertising campaign measurement and optimization technology, DeepIntent Outcomes™. Since its launch in April 2021, DeepIntent Outcomes has been used to automatically optimize media based on real-world clinical data for 85 leading pharmaceutical brands, with over 50 brands benefiting from DeepIntent Outcomes year to date.

Additionally, nearly two-thirds (65%) of all impressions served today via DeepIntent’s demand side platform (DSP) are optimized toward higher audience quality and prescription (script) performance, meeting healthcare marketers’ demand for technology that can deliver quantifiable results.

Marketing Technology News:  Screena Releases the 1ST Movie Set in the Sandbox, Announces Its Plan to Build a Metaverse…

To prove business impact, IPG’s activation intelligence company, Matterkind, turned to DeepIntent Outcomes to maximize a client’s addressable media investment as measured by script volume and new-to-brand (NBRx) scripts. As the agency of record for the provider and patient sides of the business, Matterkind used script optimization and a mix of connected TV (CTV), online video, and display ads to reach audiences.

Using Outcomes to automatically optimize the campaign, Matterkind saw prescribing rates from healthcare providers increase by 10% after campaign exposure, and patients were 225% more likely to follow through in filling their prescriptions. Ultimately, the campaign grew NBRx by 12X while reducing the cost-per-script by 60%. In addition, channel analysis found that CTV ads were twice as effective as other channels in driving script performance.

“With DeepIntent Outcomes, Matterkind goes beyond front-end metrics like views and completion rates and quantifies the real-world impact of our campaigns. More importantly, we can measure how our results improve over time across channels as the platform optimizes the campaign toward goals we set,” said Adam Thomas, vice president of addressable strategy at Matterkind. “By analyzing our recent data, we can see that CTV ads help generate top-of-funnel awareness and helps patients make informed decisions so they follow through with filling prescriptions from their providers.”

Marketing Technology News: MarTech Interview with Chris Knowlton, Chief Evangelist at Panopto

buy modafinil where to buy modafinil
instant payday loans online guaranteed approval no denial payday loans direct lenders only